SOPHiA GENETICS
UPCOMING
Starts Here in
d, hrs, min,
s
In this webinar, you will discover how the adoption of the SOPHiA DDM™ platform in combination with Microsoft Azure enables accurate analysis of complex genomics data and reduces the burden of building and maintaining IT infrastructures. This comb...
On-demand
-
Wednesday, September 15, 2021 · 11:00 AM EDTSOPHiA DDM™ enables real-time SARS-CoV-2 surveillance, enabling the detection of new and emerging strains with high accuracy and confidence. Furthermore, as vaccination efforts improve around the globe, the use of SOPHiA DDM™ provides access to ne...
-
On-DemandThis corporate satellite was presented live at ESHG 2021 on August 28th, 2021.
Next-Generation Sequencing (NGS) is rapidly improving research efforts for rare and inherited diseases. The adoption of exome sequencing helps determine the variations... -
On-DemandThis talk was presented at CGC 2021 on August 2nd, 2021. Join our experts to learn more about how the SOPHiA DDMTM platform supports solid tumor detection. -
Tuesday, June 22, 2021 · 11:00 AM EDTHereditary cancer syndromes are a set of complex diseases, often presenting with diverse clinical phenotypes, involving multiple genes of interest with variable penetrance. Large scale genomic sequencing of multi-gene panels has become the standar...
-
On-DemandSOPHiA GENETICS has demonstrated a proof of concept for real time global variant surveillance of spike protein mutations through the SOPHiA GENETICS' secured peer-network and compared findings to the GISAID timeline. Paragon Genomics SARS-CoV-2 pa... -
On-DemandThe rate of SARS-CoV-2 transmission continues to challenge the community's ability to monitor and control the spread of COVID-19. In this discussion, our expert will share insights on the different approaches to monitor viral genome sequences and ... -
On-DemandOver the last decade, whole-exome sequencing has emerged as a comprehensive and cost-effective tool for researching rare disease-causing variants, including copy number variants (CNVs). As a result, researchers can gain extensive, valuable informa...
-
On-DemandThis webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.
Molecular profiling by next... -
On-DemandThis webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources.
The evolution of molecular oncolog... -
On-DemandLas variaciones en el número de copias (CNV) del ADN son una causa bien documentada de enfermedad genética humana. La detección de CNV es un reto ya que las soluciones analíticas deben alcanzar una resolución a nivel de exón para ofrecer resultado...
-
On-DemandThis scientific evidence-webinar will discuss Genotypos Science Labs’ experience with a whole exome sequencing solution, supporting the detection of copy number variants for the management of a complex cases. DNA copy number variations (CNVs) are ...
